Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides
What is the purpose of this trial?
The purpose of this study is to determine if vorinostat combined with low-dose total skin electron beam therapy (TSEBT) offers superior clinical benefit (efficacy & safety) over low-dose TSEBT alone.
- 18 Years - N/A
- Stanford University
- December 2010
- Last Updated:
- March 7, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT01187446